[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
August 22/29, 2001

New Advice for Women Patients About Hormone Therapy and the Heart

Author Affiliations

Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001American Medical Association

JAMA. 2001;286(8):907. doi:10.1001/jama.286.8.907-JMN0822-2-1

After years of taking the opposite tack, the American Heart Association (AHA) is recommending that hormone replacement therapy (HRT) should not be initiated for secondary prevention of cardiovascular disease (CVD) in postmenopausal women.

The recommendation follows results from clinical trials suggesting that no overall cardiovascular benefit results, and a possible early increased risk of CVD events occurs, when women with documented atherosclerosis begin to take HRT (estrogen typically combined with a progestin).

First Page Preview View Large
First page PDF preview
First page PDF preview